Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction?
Journal
Translational Cancer Research
Journal Volume
5
Pages
S192-S195
Date Issued
2016
Author(s)
SDGs
Other Subjects
ADAM10 endopeptidase; antivirus agent; beta catenin; cyclin G1; glycogen synthase kinase 3beta; host factor; interferon; microRNA 122; antiviral therapy; cancer recurrence; chemoembolization; chronic hepatitis C; cytokine response; Editorial; health care quality; human; liver cell carcinoma; liver cirrhosis; liver fibrosis; prevalence; protein blood level; recurrence risk; retrospective study; treatment response; tumor growth; tumor recurrence
Publisher
AME Publishing Company
Type
editorial